These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists. Korsgaard J, Ledet M. Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239 [Abstract] [Full Text] [Related]
4. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma. Wang Y, Wang CZ, Lin KX, Qian GS, Zhuo WL, Li SP, Zhao ZQ, Liao XQ, Song YX. Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184 [Abstract] [Full Text] [Related]
5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM, White CM, Coleman CI. Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [Abstract] [Full Text] [Related]
6. Beliefs about medicines predict refill adherence to inhaled corticosteroids. Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, Horne R. J Psychosom Res; 2008 Jan; 64(1):47-54. PubMed ID: 18157999 [Abstract] [Full Text] [Related]
9. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study). Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L. Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):569-79. PubMed ID: 15317039 [Abstract] [Full Text] [Related]
10. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506 [Abstract] [Full Text] [Related]
11. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Akazawa M, Biddle AK, Stearns SC. Clin Ther; 2008 Jun; 30 Spec No():1003-16. PubMed ID: 18640475 [Abstract] [Full Text] [Related]
13. Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting. Molimard M, Le Gros V, Robinson P, Bourdeix I. J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):91-5. PubMed ID: 19778267 [Abstract] [Full Text] [Related]
14. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA, Fabbri LM, Davis KJ, Soriano JB. Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [Abstract] [Full Text] [Related]
16. A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Foster JM, van Sonderen E, Lee AJ, Sanderman R, Dijkstra A, Postma DS, van der Molen T. Respir Res; 2006 Oct 24; 7(1):131. PubMed ID: 17062139 [Abstract] [Full Text] [Related]
17. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM. Curr Med Res Opin; 2009 Sep 24; 25(9):2251-8. PubMed ID: 19622006 [Abstract] [Full Text] [Related]
18. [Inhaled corticosteroid therapy in adults with asthma. Current evidences]. Foresi A, Pelucchi A, Del Donno M, Marangio E, Olivieri D. Recenti Prog Med; 2005 Oct 24; 96(10):469-73. PubMed ID: 16491767 [Abstract] [Full Text] [Related]